These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11904356)

  • 21. The localization of aluminium and other elements in bone tissue of a case of renal osteodystrophy with an associated dialysis encephalopathy syndrome.
    McClure J; Smith PS
    J Pathol; 1984 Apr; 142(4):293-9. PubMed ID: 6716213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water.
    Willhite CC; Ball GL; McLellan CJ
    Crit Rev Toxicol; 2012 May; 42(5):358-442. PubMed ID: 22512666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH.
    Coen G; Ballanti P; Bonucci E; Calabria S; Costantini S; Ferrannini M; Giustini M; Giordano R; Nicolai G; Manni M; Sardella D; Taggi F
    Nephron; 2002 May; 91(1):103-11. PubMed ID: 12021526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aluminium-induced osteomalacia in severe chronic renal failure (SCRF).
    Visser WJ; Van de Vyver FL
    Clin Nephrol; 1985; 24 Suppl 1():S30-6. PubMed ID: 3915958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-dependent effects of strontium on osteoblast function and mineralization.
    Verberckmoes SC; De Broe ME; D'Haese PC
    Kidney Int; 2003 Aug; 64(2):534-43. PubMed ID: 12846748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Renal osteodystrophy: aluminium and secondary hyperparathyroidism].
    de Vernejoul MC
    Rev Prat; 1990 Mar; 40(7):613-8. PubMed ID: 2326587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of aluminium on the development of hyperparathyroidism and bone disease in the azotaemic rat.
    Felsenfeld AJ; Machado L; Bover J; Trinidad P; Rodriguez M
    Nephrol Dial Transplant; 1993; 8(4):325-34. PubMed ID: 8390007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A potential relationship between long-term fluoride exposure and incidence of metabolic bone disease in renal failure.
    Stanbaugh G; Taves D; Hobbs L; Myers WD
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():96-8. PubMed ID: 756049
    [No Abstract]   [Full Text] [Related]  

  • 30. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron overload and bone disease in chronic dialysis patients.
    Van de Vyver FL; Visser WJ; D'Haese PC; De Broe ME
    Nephrol Dial Transplant; 1990; 5(9):781-7. PubMed ID: 2129351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative roles of intestinal absorption and dialysis-fluid-related exposure in the accumulation of aluminium in haemodialysis patients.
    Mazzaferro S; Perruzza I; Costantini S; Pasquali M; Onorato L; Sardella D; Giordano R; Ciaralli L; Ballanti P; Bonucci E; Cinotti GA; Coen G
    Nephrol Dial Transplant; 1997 Dec; 12(12):2679-82. PubMed ID: 9430871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of adynamic bone disease diagnosed by biochemical markers in a wide sample of the European CAPD population.
    Couttenye MM; D'Haese PC; Deng JT; Van Hoof VO; Verpooten GA; De Broe ME
    Nephrol Dial Transplant; 1997 Oct; 12(10):2144-50. PubMed ID: 9351080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Water content of aluminum, dialysis dementia, and osteomalacia.
    Wills MR; Savory J
    Environ Health Perspect; 1985 Nov; 63():141-7. PubMed ID: 3908086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The aplastic form of renal osteodystrophy.
    Sherrard DJ; Hercz G; Pei Y; Segre G
    Nephrol Dial Transplant; 1996; 11 Suppl 3():29-31. PubMed ID: 8840308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal osteodystrophy in Ramathibodi Hospital: histomorphometry and clinical correlation.
    Changsirikulchai S; Domrongkitchaiporn S; Sirikulchayanonta V; Ongphiphadhanakul B; Kunkitti N; Stitchantrakul W; Radienahamed P
    J Med Assoc Thai; 2000 Oct; 83(10):1223-32. PubMed ID: 11143489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone.
    Farlay D; Boivin G; Panczer G; Lalande A; Meunier PJ
    J Bone Miner Res; 2005 Sep; 20(9):1569-78. PubMed ID: 16059629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of serum aluminium monitoring in dialysis patients: a multicentre study.
    D'Haese PC; Clement JP; Elseviers MM; Lamberts LV; Van de Vyver FL; Visser WJ; De Broe ME
    Nephrol Dial Transplant; 1990; 5(1):45-53. PubMed ID: 2109284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localisation of aluminium by histochemical and electron probe x-ray microanalytical techniques in bone tissue of cases of renal osteodystrophy.
    Smith PS; McClure J
    J Clin Pathol; 1982 Nov; 35(11):1283-93. PubMed ID: 7142436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aluminium and strontium in calcium supplements and antacids: a concern to haemodialysis patients?
    Da Silva E; Jakubovic R; Pejovic-Milic A; Heyd DV
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2010 Oct; 27(10):1405-14. PubMed ID: 20640960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.